New Key Statistics Module, Z-Score and F-Score
NAS:CYTH Key Ratios
| Market Cap $ M | 40.78 |
| Enterprise Value $ M | 31.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 8.35 |
| Price/Sales | 21.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -1.00 |
| Beneish M-Score | -1.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 28.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.60 |
| EV-to-EBITDA | -1.60 |
| PEG | -- |
| Shares Outstanding M | 28.72 |
| Net Margin (%) | -1,865.67 |
| Operating Margin % | -1,865.12 |
| Pre-tax Margin (%) | -1,865.67 |
| Quick Ratio | 1.42 |
| Current Ratio | 1.45 |
| ROA % (ttm) | -315.35 |
| ROE % (ttm) | -3,987.28 |
| ROIC % (ttm) | -2,077.29 |
| Dividend Yield % | -- |
| Altman Z-Score | -10.59 |
CYTH Number of Guru Trades
CYTH Volume of Guru Trades
Gurus Latest Trades with NAS:CYTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CYTH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cyclo Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CYTH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers